Table 1.

Galantamine Trial: Baseline Characteristics of Smoking Participants By Treatment Assignment

Baseline Characteristics	Galantamine (N=18)		Placebo (N=23)
	Mean	S.D.	Mean	S.D.	t	df	P-value
Age, years	50.4	6.0	45.3	11.3	1.89	38.1	0.066*
Education, years	12.0	1.2	12.4	2.2	−0.83	38.2	0.41*
BPRS total score	33.7	8.1	37.2	10.5	01.17	41	0.25
BPRS psychosis	9.9	4.9	11.9	4.8	−1.28	41	0.21
BPRS anxiety/depression	8.1	2.9	8.4	3.6	−0.28	41	0.78
SANS total score	30.2	13.0	28.0	10.5	−0.60	40	0.55
CGI Severity score	4.3	0.7	4.4	0.8	−0.29	41	0.77
	n	%	n	%	χ2	df	P-value**
Female gender	1	5.6	1	4.0	0.06	1	1.00*
Race:					1.18	2	0.73*
White	7	38.9	7	28.0
Black	11	61.1	17	68.0
Other	0	0.0	1	4.0
Antipsychotic:					4.46	4	0.46*
Olanzapine	12	66.7	14	56.0
Risperidone	5	28.8	7	30.4
Quetiapine	0	0.0	2	8.7
Aripiprazole	1	5.6	0	0.0
Polypharmacy	0	0.0	2	8.0

^*t-tests for age and education level performed using Satterthwaite's approximation due to evidence of inequality of variances in the two group.

^**P-values calculated from Fisher's exact test due to small n's in some cells.